Healthcare >> CEO Interviews >> May 7, 2001

Toni Schuh – Sequenom Inc (sqnm)

TONI SCHUH was appointed President and CEO of SEQUENOM, Inc., and also a member of its Board of Directors in May 2000. He has been a member of SEQUENOM's executive team since 1996 and played a leading role in implementing SEQUENOM's business strategy, directing the company's MassARRAY_ system launch and developing commercial and strategic partnerships. Dr. Schuh joined SEQUENOM as Managing Director of its German operations in 1996 and was appointed Corporate Executive Vice President of Business Development in 1998. Before joining SEQUENOM, Dr. Schuh was Head of the Pharma Business Development Group at Helm AG, one of the world's largest chemical and pharmaceutical distribution corporations. Prior to that, he held an international management position at Fisons Pharmaceuticals. Dr. Schuh holds a PhD in pharmaceutical chemistry from the University of Bonn, Germany. Profile
TWST: Can we start out with a quick update on SEQUENOM, what's gone on

at the company over the past year or so that investors should be aware


Dr. Schuh: SEQUENOM has met many milestones